Sigma Genetics
PrivateLast Round
Seed
May 7, 2026
Est. Valuation
$1.71M
Total Funding Raised
$3.74M
Company Overview
Sigma Genetics operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was an Accelerator round in March 2026.
Sigma Genetics is a biotechnology company that develops gene delivery platforms, including the Magnetoporator™ device, to enable scalable and high-efficiency cell engineering for drug discovery and therapeutic manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment, Defense Tech
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sigma Genetics Comparables
Compare Sigma Genetics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kytopen | 79% | |
| CellFE | 79% | |
| Celetrix | 78% |
For institutional investors. Book with your work email.
Sigma Genetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 7, 2026 | ||||
| Accelerator | Mar 23, 2026 | ||||
| Grant | Aug 8, 2023 | ||||
| Seed | Jan 27, 2022 | ||||
| Accelerator | Mar 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sigma Genetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Tech Center | Accelerator |
| Capital Factory | Seed |
| Asymmetry Ventures | Seed |
| Y Combinator | Accelerator, Seed |
| Healthspan Capital | Seed |
| AFVentures | Grant |
| Biosphere Investment Group | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 46% month-over-month.
- Aug 8, 2023
Secured $1.73M in grant funding from AFVentures and Andy Hill Cancer Research Endowment Fund.
For institutional investors. Book with your work email.
Sigma Genetics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sigma Genetics's valuation, stock price, and market status.
Is Sigma Genetics a public or private company?
Sigma Genetics is a private company.
What is the current stock price of Sigma Genetics?
Sigma Genetics is a private company, so its shares have no public market price. Caplight tracks Sigma Genetics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sigma Genetics worth (valuation)?
Sigma Genetics's valuation is estimated at $1.7M based on funding round data.
Can I buy Sigma Genetics stock?
Sigma Genetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sigma Genetics's last funding round?
Sigma Genetics's most recent funding round was Seed on May 7, 2026.
Who are the main investors in Sigma Genetics?
Key investors in Sigma Genetics include Plug and Play Tech Center, Capital Factory, Asymmetry Ventures, Y Combinator, Healthspan Capital.
Will Sigma Genetics IPO soon?
No public IPO plans have been announced for Sigma Genetics.
How can I track Sigma Genetics secondary market activity?
Caplight tracks bids, offers, and trades in Sigma Genetics's shares on secondary markets.